tirzepatide and long covid Treatment Trial-Tirzepatide (LoCITT-T) Webinar: Learn How to Participate From Home | Video Long COVID - COVID-19 Actuaries
Description
Zepbound (tirzepatide), a new weight management medication by Eli Lilly, has shown promising results
However, the cost of treatment remains a barrier for many
Yes, rapidly
Mounting evidence suggests that the drugs have a broad anti-inflammatory effect on the bodya mechanism thats of interest for treating long Covid
The study found that SARS-CoV-2 reacted with 28 of them including barrier proteins (such as those seen in leaky gut), thyroid proteins and brain tissue
